Delivery Order SPE2DB20D1109-SPE2DB23FN22C
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the drug Xeomin. The contract has a firm fixed price of $6,155.52 and a completion date of January 18, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,145.44 firm fixed-price contract is for the delivery of 200-unit vials of the medication Xeomin, with a completion date of February 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the medication Xeomin. The contract has a firm fixed price of $25,145.00 and a completion date of November 22, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This is a delivery order worth $3,145.50 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 200-unit vials of the pharmaceutical product Xeomin. The contract has a firm fixed-price pricing structure and a completion date of September 30, 2024. AmerisourceBergen is a large pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the drug Xeomin. The contract has a firm fixed price of $7,863.60 and a completion date of March 13, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the drug Xeomin. The $15,727.50 firm fixed-price contract has an ultimate completion date of August 14, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,557,391,691 units of the drug XEOMIN (200 unit vials). The $7,181.44 firm fixed-price delivery order has a completion date of June 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,644.72 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Xeomin 200 unit vials. The contract utilizes firm fixed price terms with an ultimate completion date of June 24, 2025, and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet federal procurement...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,193.92, is for the delivery of XEOMIN 200 unit vials. The award has an ultimate completion date of August 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,117.48 by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Xeomin 100 Unit Vials. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 28, 2025, and represents a child order under a larger contract vehicle. The award carries no set-aside designation, reflecting open...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN22CDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $6,155.52 in Xeomin 200 unit vials. The award is a firm fixed-price contract with a completion date of January 17, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a comprehensive range of pharmaceutical products and medical supplies. This delivery order is not designated as a set-aside contract. The contract supports the procurement of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and other supplies for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 12/22/22 |